Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Trojano

Showing results (171-180 of 342) with videos related to

Pageof 35
Sort By:
Current Neurovascular Research|November 27, 2013
Age-related vascular differences among patients suffering from multiple sclerosisFrancesco Ciciarello, Sandro Mandolesi, Aldo Innocente Galeandro, et al.
Human Molecular Genetics|November 1, 2017
Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the diseaseMaria Liguori, Nicoletta Nuzziello, Flavio Licciulli, et al.
Rheumatology (Oxford, England)|December 5, 2021
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathyAnna Lia, Tiziana Annese, Marco Fornaro, et al.
Journal of Neuroimmunology|October 25, 2003
Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosisEva Akesson, Francesca Coraddu, Maria Giovanna Marrosu, et al.
Journal of Neuroimmunology|July 17, 2003
CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markersMacarena Gomez-Lira, Maria Liguori, Corrado Magnani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2016
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched studyIlya Kister, Tim Spelman, Raed Alroughani, et al.
Expert Opinion on Drug Delivery|March 1, 2016
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER studyDamiano Paolicelli, Eleonora Cocco, Valentina Di Lecce, et al.
Human Immunology|February 1, 2003
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosusMarta Mellai, Mara Giordano, Sandra D'Alfonso, et al.
Multiple Sclerosis and Related Disorders|February 3, 2020
A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patientsGiulia Mallucci, Francesco Patti, Vincenzo Brescia Morra, et al.
Journal of Neurology|November 20, 2023
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patientsAlvino Bisecco, Federica Matrone, Marco Capobianco, et al.
Pageof 35

Showing results (171-180 of 342) with videos related to

Sort By:
Pageof 35
Current Neurovascular Research|November 27, 2013
Age-related vascular differences among patients suffering from multiple sclerosisFrancesco Ciciarello, Sandro Mandolesi, Aldo Innocente Galeandro, et al.
Human Molecular Genetics|November 1, 2017
Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the diseaseMaria Liguori, Nicoletta Nuzziello, Flavio Licciulli, et al.
Rheumatology (Oxford, England)|December 5, 2021
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathyAnna Lia, Tiziana Annese, Marco Fornaro, et al.
Journal of Neuroimmunology|October 25, 2003
Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosisEva Akesson, Francesca Coraddu, Maria Giovanna Marrosu, et al.
Journal of Neuroimmunology|July 17, 2003
CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markersMacarena Gomez-Lira, Maria Liguori, Corrado Magnani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2016
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched studyIlya Kister, Tim Spelman, Raed Alroughani, et al.
Expert Opinion on Drug Delivery|March 1, 2016
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER studyDamiano Paolicelli, Eleonora Cocco, Valentina Di Lecce, et al.
Human Immunology|February 1, 2003
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosusMarta Mellai, Mara Giordano, Sandra D'Alfonso, et al.
Multiple Sclerosis and Related Disorders|February 3, 2020
A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patientsGiulia Mallucci, Francesco Patti, Vincenzo Brescia Morra, et al.
Journal of Neurology|November 20, 2023
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patientsAlvino Bisecco, Federica Matrone, Marco Capobianco, et al.
Pageof 35